Hints and tips:
Related Special Reports
...The company has been working with the pharmaceutical giant GSK, focusing on immuno-oncology drugs....
...Scientists hope the new data release will deepen knowledge of the biological causes of diseases and help improve the use of “precision medicines” tailored to individuals’ genetic and health profiles....
...The UK drugmaker will take charge of biological data analysis and carry out genetic and drug screening, while the Cambridge start-up will focus on the molecular biology of synthetic viability....
...His pitch was that Altos would hire the best minds in the business — including the former GSK chief scientific officer Hal Barron as chief executive — and set them free....
...Its manufacturing order backlogs are up 25 per cent to $7.5bn on surging demand for coronavirus treatments offered by US drugmaker Eli Lilly and the UK’s GSK and AstraZeneca....
...For science graduates, large drugmakers, including GSK and AstraZeneca, and research organisations, such as Cancer Research, run graduate trainee schemes, while King’s College London offers an integrated...
...In October, the health ministry declared a “biological emergency on a regional scale” in response to the outbreak in the Rivne region in the country’s west....
...The company is partnering with GSK to use its adjuvant to boost the immune system’s response. Vaccine type: Recombinant spike protein in two doses....
...biological treatments, which have been a more successful area for R&D....
...The three companies receiving the approvals are CanSino Biologics, Sinovac Biotech, and the Wuhan Institute of Biological Products, the state news agency has said....
...Chongqing Zhifei Biological Products Sector: pharmaceuticals / HQ: Jiangbei, China In early December, Chongqing Zhifei Biological Products became China’s fourth pharmaceutical group to start final stage...
...Chongqing Zhifei Biological Products is listed in Shenzhen, focusing on vaccine R&D and sales....
...The investment will allow the company to expand work within its existing research facilities in identifying biological targets that may lead to the development of new drugs....
...Large pharmaceutical companies including Johnson & Johnson, AstraZeneca and GSK are also joining forces to train their own machine learning algorithms for drug discovery on each other’s data....
...Of the top 25, GSK's Emma Walmsley was the only woman....
...Meanwhile, after six years as president of AstraZeneca subsidiary MedImmune, Bahija Jallal was this month appointed chief executive of Immunocore which develops biological drugs to treat cancer, infectious...
...Patrick Vallance, GSK’s chief scientist, said the company’s £40m investment will allow it to expand its research into identifying biological characteristics that could lead to new drugs for patients, as...
...Encourage them to find something, anything, that is vaguely active in a biological system, and then market it as though in were the holy Bible....
...In her previous role running the UK’s Biotechnology and Biological Sciences Research Council, Prof Hunter became very interested in the analysis and curation of big data....
...A trigger point, at which GSK would be obliged to buy out the Swiss company’s 36.5 per cent stake if Novartis opted to sell, falls due in March 2018....
...“UK Biobank has amassed an enormous amount of securely stored health, lifestyle, medical and biological data,” said Sir Rory Collins, Biobank’s leader....
...But the next batch of drugs set to lose their patents are not easy to copy; rather, they are “biological” medicines that are harvested from living cells....
...A powerful new force in bioelectronics – using electrical signals rather than chemical or biological drugs to treat disease – has been created by GlaxoSmithKline in partnership with Alphabet, Google’s holding...
...At Barnard Castle, a £92m investment will fund the construction of a sterile facility to make biological molecules....
...At Barnard Castle in County Durham, a £92m investment will fund the construction of a sterile facility to make biological molecules, including an experimental antibody for severe asthma that GSK is buying...
International Edition